BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19617848)

  • 21. Evaluation of Immunostimulatory Effects of N-(2-Hydroxy) Propyl-3-Trimethylammonium Chitosan Chloride for Improving Live Attenuated Hepatitis A Virus Vaccine Efficacy.
    Tao W; Fu T; He Z; Hu R; Jia L; Hong Y
    Viral Immunol; 2017 Mar; 30(2):120-126. PubMed ID: 27918250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Vaccination on Distribution of T Cell Subsets in Antiretroviral-Treated HIV-Infected Children.
    Thitilertdecha P; Khowawisetsut L; Ammaranond P; Poungpairoj P; Tantithavorn V; Onlamoon N
    Dis Markers; 2017; 2017():5729639. PubMed ID: 28694558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.
    Al-Harthi L; Voris J; Du W; Wright D; Nowicki M; Frederick T; Landay A; Kovacs A
    J Infect Dis; 2006 May; 193(9):1202-10. PubMed ID: 16586355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological efficacy of a three-dose schedule of hepatitis A vaccine in HIV-infected adults: HEPAVAC study.
    Launay O; Grabar S; Gordien E; Desaint C; Jegou D; Abad S; Girard PM; Bélarbi L; Guérin C; Dimet J; Williams V; Krivine A; Salmon D; Lortholary O; Rey D;
    J Acquir Immune Defic Syndr; 2008 Nov; 49(3):272-5. PubMed ID: 18845961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of booster vaccination on combined hepatitis A and hepatitis B vaccine in both anti-HBs and anti-HAV negative children 5-15 years after hepatitis B vaccine primary immunization.
    Chen Y; Gu H; Cheng S; Shen L; Cui F; Wang F; Yao J; Xia S; Lv H; Liang X
    Hum Vaccin Immunother; 2013 Apr; 9(4):898-902. PubMed ID: 23295964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 years.
    Van Herck K; Jacquet JM; Van Damme P
    J Med Virol; 2011 Nov; 83(11):1885-91. PubMed ID: 21915861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Older age is associated with peripheral blood expansion of naïve B cells in HIV-infected subjects on antiretroviral therapy.
    Van Epps P; Matining RM; Tassiopoulos K; Anthony DD; Landay A; Kalayjian RC; Canaday DH
    PLoS One; 2014; 9(9):e107064. PubMed ID: 25207968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T cell anergy and activation are associated with suboptimal humoral responses to measles revaccination in HIV-infected children on anti-retroviral therapy in Nairobi, Kenya.
    Buechler MB; Newman LP; Chohan BH; Njoroge A; Wamalwa D; Farquhar C
    Clin Exp Immunol; 2015 Sep; 181(3):451-6. PubMed ID: 25739813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term Durability of Responses to 2 or 3 Doses of Hepatitis A Vaccination in Human Immunodeficiency Virus-Positive Adults on Antiretroviral Therapy.
    Cheng A; Chang SY; Sun HY; Tsai MS; Liu WC; Su YC; Wu PY; Hung CC; Chang SC
    J Infect Dis; 2017 Feb; 215(4):606-613. PubMed ID: 28011921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune response to hepatitis A vaccine in patients with HIV.
    Fritzsche C; Bergmann L; Loebermann M; Glass A; Reisinger EC
    Vaccine; 2019 Apr; 37(16):2278-2283. PubMed ID: 30890384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of vaccination against hepatitis A in HIV infected adults from Lodz region--preliminary report].
    Jabłonowska E; Kuydowicz J; Małolepsza E
    Przegl Epidemiol; 2008; 62(3):605-12. PubMed ID: 19108525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals.
    Rallón NI; Soriano V; Restrepo C; García-Samaniego J; Labarga P; López M; Peris A; González-Lahoz J; Benito JM
    J Acquir Immune Defic Syndr; 2011 May; 57(1):1-8. PubMed ID: 21786458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy.
    Abzug MJ; Warshaw M; Rosenblatt HM; Levin MJ; Nachman SA; Pelton SI; Borkowsky W; Fenton T;
    J Infect Dis; 2009 Sep; 200(6):935-46. PubMed ID: 19663708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine.
    Van Damme P; Leroux-Roels G; Suryakiran P; Folschweiller N; Van Der Meeren O
    Hum Vaccin Immunother; 2017 May; 13(5):972-980. PubMed ID: 28281907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan.
    Lee YL; Lin KY; Cheng CY; Li CW; Yang CJ; Tsai MS; Tang HJ; Lin TY; Wang NC; Lee YC; Lin SP; Huang YS; Sun HY; Zhang JY; Ko WC; Cheng SH; Lee YT; Liu CE; Hung CC;
    PLoS One; 2017; 12(10):e0186338. PubMed ID: 29036227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
    Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The induction of CD80 and apoptosis on B cells and CD40L in CD4+ T cells in response to seasonal influenza vaccination distinguishes responders versus non-responders in healthy controls and aviremic ART-treated HIV-infected individuals.
    Powell AM; Luo Z; Martin L; Wan Z; Ma L; Liao G; Song Y; Li X; Michael Kilby J; Huang L; Jiang W
    Vaccine; 2017 Feb; 35(5):831-841. PubMed ID: 28017428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity of booster vaccination with a virosomal hepatitis A vaccine after primary immunization with an aluminum-adsorbed hepatitis A vaccine.
    Beck BR; Hatz CF; Loutan L; Steffen R
    J Travel Med; 2004; 11(4):201-6. PubMed ID: 15541221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of humoral response to recommended vaccines in HIV-infected adults.
    Tsachouridou O; Christaki E; Skoura L; Georgiou A; Nanoudis S; Vasdeki D; Ntziovara MA; Kotoreni G; Forozidou E; Tsoukra P; Germanidis G; Metallidis S
    Comp Immunol Microbiol Infect Dis; 2017 Oct; 54():27-33. PubMed ID: 28915998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Humoral and cellular response to influenza vaccine in HIV-infected children with full viroimmunologic response to antiretroviral therapy.
    Viganò A; Zuccotti GV; Pacei M; Erba P; Castelletti E; Giacomet V; Amendola A; Pariani E; Tanzi E; Clerici M
    J Acquir Immune Defic Syndr; 2008 Jul; 48(3):289-96. PubMed ID: 18545155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.